Actionable news
All posts from Actionable news
Actionable news in PFE: PFIZER Inc,

Inotek Pharma readies mid-stage study of combo drug to treat glaucoma

Inotek Pharmaceuticals (NASDAQ:ITEK) initiates a Phase 2 dose-ranging study of a fixed-dose combination of trabodenoson and latanoprost in an eye-drop formulation for the treatment of glaucoma.

The 165-subject study will randomize patients with ocular hypertension or primary open-angle...